News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
822,841 Results
Type
Article (85153)
Company Profile (621)
Press Release (737067)
Section
Business (231580)
Career Advice (4090)
Deals (39618)
Drug Delivery (106)
Drug Development (90355)
Employer Resources (192)
FDA (17841)
Job Trends (17242)
News (394159)
Policy (39559)
Tag
Academia (2970)
Africa (1260)
Alliances (56285)
Alzheimer's disease (1237)
Approvals (17770)
Arizona (200)
Artificial intelligence (72)
Asia (48915)
Australia (8609)
Bankruptcy (392)
Best Places to Work (12216)
Biosimilars (71)
Biotechnology (438)
C2C Services and Suppliers (95111)
California (1762)
Canada (815)
Cancer (469)
Career advice (3497)
Cell therapy (138)
China (132)
Clinical research (70316)
Collaboration (132)
Compensation (71)
Connecticut (65)
COVID-19 (2743)
Cystic fibrosis (76)
Data (269)
Diabetes (67)
Diagnostics (6468)
Drug pricing (65)
Earnings (93180)
Employer resources (162)
Europe (111831)
Events (124695)
Executive appointments (133)
FDA (17997)
Florida (204)
Funding (133)
Gene therapy (103)
GLP-1 (584)
Government (4993)
Healthcare (20591)
Hotbed/Location (534575)
Illinois (279)
Indiana (142)
Infectious disease (2763)
Inflammatory bowel disease (101)
Interviews (805)
IPO (17456)
Job creations (5172)
Job search strategy (2849)
Kansas (100)
Layoffs (463)
Legal (9999)
Lung cancer (108)
Manufacturing (87)
Maryland (406)
Massachusetts (1569)
Medical device (14189)
Medtech (14194)
Mergers & acquisitions (21922)
Metabolic disorders (245)
Michigan (118)
Minnesota (207)
Neuroscience (1386)
New Jersey (542)
New York (542)
NextGen Class of 2024 (7621)
Non-profit (5043)
North Carolina (669)
Northern California (737)
Obesity (141)
Ohio (94)
Opinion (234)
Patents (70)
Pennsylvania (510)
People (63626)
Pharmaceutical (118)
Phase I (21608)
Phase II (30534)
Phase III (23066)
Pipeline (94)
Podcasts (76)
Postmarket research (3529)
Preclinical (9761)
Press Release (72)
Rare diseases (130)
Real estate (7358)
Recruiting (72)
Regulatory (25516)
Research institute (2631)
Resumes & cover letters (645)
South America (1641)
Southern California (697)
Startups (4269)
Texas (203)
United States (8220)
Vaccines (548)
Washington State (262)
Weight loss (141)
Date
Today (104)
Last 7 days (541)
Last 30 days (1887)
Last 365 days (38319)
2024 (26503)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
822,841 Results for "goldfinch bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Karuna Therapeutics Announces Exclusive Global License Agreement for Goldfinch Bio’s Investigational TRPC4/5 Product Candidates
Karuna Therapeutics, Inc. (NASDAQ: KRTX) and GFB (ABC), LLC, assignee of the Goldfinch Bio assignment estate, today announced their entry into an exclusive license agreement under which Karuna will obtain global development, manufacturing, and commercialization rights to Goldfinch Bio’s investigational transient receptor potential canonical 4 and 5 (TRPC4/5) channel candidates, including lead clinical-stage candidate GFB-887.
February 2, 2023
·
5 min read
Deals
Karuna Plucks Goldfinch’s TRPC4/5 Assets for Anxiety, Mood Disorders
Karuna Therapeutics acquired exclusive rights to Goldfinch Bio’s investigational TRPC4/5 channel candidates in a deal potentially worth $520 million.
February 2, 2023
·
2 min read
·
Hayley Shasteen
Layoffs
IN8bio to Lay Off About 49% of Employees
Facing financial challenges, IN8bio is looking to preserve cash resources through a pipeline prioritization and layoffs at its New York City and Birmingham, Alabama, sites.
September 5, 2024
·
1 min read
·
Angela Gabriel
Genetown
Goldfinch Bio to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
Goldfinch Bio today announced that Anthony Johnson, M.D., President and Chief Executive Officer of Goldfinch Bio, will participate in a panel discussion, Casino Re-nal – Novel Mechanisms in Renal Disorders , at the Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 9, 2022.
August 2, 2022
·
1 min read
BioMidwest
Aruna Bio to Present at BIO International Convention 2024
Aruna Bio, Inc. announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the 2024 BIO International Convention being held June 3-6, 2024 at the San Diego Convention Center, California.
May 28, 2024
·
1 min read
Collaboration
Novartis, Dren Bio Ink Potential $3B Deal for Anti-Myeloid Bispecific Antibodies for Cancer
Novartis continues its dealmaking spree with a bet on Dren Bio’s Targeted Myeloid Engager and Phagocytosis platform to develop bispecific antibodies in oncology.
July 25, 2024
·
2 min read
·
Tristan Manalac
Lone Star Bio
Matica Bio at BIO International 2024: Leading the Way in CGT Innovation and U.S. Manufacturing Strategy
Matica Biotechnology (Matica Bio) announced today that it will participate in the world’s largest biotech exhibition, the BIO International Convention (BIO USA).
May 22, 2024
·
4 min read
Pharm Country
BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention
BlueSphere Bio today announced that Keir Loiacono, Esq., Chief Executive Officer of BlueSphere Bio, will provide a corporate update and participate in a panel discussion at the 2024 BIO International convention being held from June 3 – 6, 2024.
May 30, 2024
·
3 min read
Biotech Beach
GRI Bio to Present at the 8th Annual IPF Summit
GRI Bio, Inc. today announced that Vipin Kumar Chaturvedi, PhD, Chief Scientific Officer of GRI Bio, will present at the 8th Annual IPF Summit taking place August 20-22, 2024 in Boston, MA.
July 1, 2024
·
4 min read
SAb Biotherapeutics Rebrands as SAB BIO
SAB Biotherapeutics today announced its new name, SAB BIO, and visual identity to more closely align with its mission to treat and prevent immune and autoimmune disorders with the use of its unique immunotherapy platform.
June 20, 2024
·
5 min read
1 of 82,285
Next